Aprameya Enginee

Why is Aprameya Engineering Ltd falling/rising?

As of 27-Aug, Aprameya Engineering Ltd's stock price is declining, currently at 126.00, reflecting a significant year-to-date drop of 60.07% and underperformance compared to the sector. The stock is trading below all moving averages, indicating a consistent downward trend, exacerbated by a 93.7% decrease in investor participation.

As of 27-Aug, Aprameya Engineering Ltd's stock price is falling, currently at 126.00, which reflects a decrease of 7.0 points or 5.26%. This decline is evident in the stock's performance over various periods, with a significant year-to-date drop of 60.07%, compared to a 7.80% decline in the Sensex. Additionally, the stock has underperformed the sector by 5.37% today.<BR><BR>The stock is trading lower than its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a consistent downward trend. Furthermore, there has been a notable decrease in investor participation, with delivery volume on 26 August falling by 93.7% compared to the 5-day average. This lack of interest from investors contributes to the stock's declining price. Overall, these factors collectively explain the downward movement in Aprameya Engineering Ltd's stock price.

Which are the latest news on Aprameya Enginee?

What does Aprameya Enginee do?

Aprameya Engineering Ltd is a micro-cap company in the hospital industry, originally formed in 2003 and incorporated as a Private Limited Company in 2021. It has a market cap of INR 267 Cr, with a P/E ratio of 53.00 and a return on equity of 7.27%.

Overview: <BR>Aprameya Engineering Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The company was originally formed as a Partnership Firm on September 05, 2003, and was registered on August 13, 2004, in Ahmedabad. It was subsequently incorporated as a Private Limited Company on December 28, 2021, following the conversion of the partnership firm.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 267 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 53.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.02 <BR>Return on Equity: 7.27% <BR>Price-to-Book: 3.85<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Aprameya Enginee?

Peers of Aprameya Enginee include GPT Healthcare, Unihealth Hosp, Chandan Healthca, and others, with varying management risks and growth rates. Unihealth Hosp leads in 1-year returns at 326.01%, while Aprameya Enginee has a return of -12.50%.

Peers: The peers of Aprameya Enginee are GPT Healthcare, Unihealth Hosp, Chandan Healthca, Lotus Eye Hospit, Vaidya Sane, Asarfi Hospital, Aashka Hospitals, and Abate As Indust.<BR><BR>Quality Snapshot: Excellent management risk is observed at GPT Healthcare, while Average management risk is found at Unihealth Hosp, Chandan Healthca, and Asarfi Hospital, and the rest have Below Average management risk. Growth is Excellent at Unihealth Hosp and Chandan Healthca, while Below Average growth is noted at Aprameya Enginee, Lotus Eye Hospit, Aashka Hospitals, and Abate As Indust, with the rest showing Average growth. Excellent capital structure is seen at GPT Healthcare and Unihealth Hosp, Good capital structure is noted at Aprameya Enginee, Chandan Healthca, Lotus Eye Hospit, Vaidya Sane, and Asarfi Hospital, while Aashka Hospitals and Abate As Indust have Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Unihealth Hosp at 326.01%, while Aprameya Enginee has a 1-year return of -12.50%, which is lower than all peers except Vaidya Sane at -29.12% and the rest with negative returns. Additionally, Vaidya Sane, Aashka Hospitals, and Abate As Indust have negative six-month returns.

How big is Aprameya Enginee?

Summary could not be generated.

As of 14th August, Aprameya Engineering Ltd has a market capitalization of 266.37 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent quarterly performance data is unavailable, so there are no figures for Net Sales or Net Profit for the latest four quarters.<BR><BR>In the balance sheet snapshot for the reporting period of March 2026, Shareholder's Funds are valued at 69.40 Cr, and Total Assets amount to 81.33 Cr.

Is Aprameya Enginee technically bullish or bearish?

As of December 1, 2025, the trend is mildly bullish with supportive indicators like a bullish MACD and daily moving averages, but mixed signals from the monthly RSI and Dow Theory suggest caution.

As of 1 December 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a bullish MACD on the weekly chart and bullish signals from the Bollinger Bands and daily moving averages. However, the monthly RSI indicates a bearish signal, which tempers the overall bullish outlook. The lack of clear trends in Dow Theory and OBV on both weekly and monthly time frames suggests caution. Overall, while there are bullish indicators, the mixed signals indicate a moderate strength in the bullish stance.

Is Aprameya Enginee overvalued or undervalued?

As of August 28, 2025, Aprameya Enginee is considered very expensive and overvalued with a PE ratio of 21.89, despite strong stock performance and a year-to-date return of 75.85%, especially when compared to its peers like Max Healthcare and Apollo Hospitals.

As of 28 August 2025, the valuation grade for Aprameya Enginee has moved from fair to very expensive. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of 21.89, an EV to EBITDA ratio of 15.64, and a ROE of 25.09%. <BR><BR>In comparison to its peers, Aprameya Enginee's PE ratio is significantly lower than that of Max Healthcare at 93.61 and Apollo Hospitals at 70.56, both of which are also categorized as very expensive. The company's stock has shown strong performance, with a year-to-date return of 75.85%, contrasting sharply with the Sensex's return of only 3.62% during the same period. This suggests that while the stock has performed well, its current valuation does not justify the high price relative to its earnings potential.

Who are the top shareholders of the Aprameya Enginee?

The top shareholders of Aprameya Enginee include Saurabh Kishorbhai Bhatt with 36.24%, Hem Finlease Private Limited at 2.7%, and individual investors holding 20.81%. There are no pledged promoter holdings or mutual funds involved.

The top shareholders of Aprameya Enginee include the promoters, with Saurabh Kishorbhai Bhatt holding the highest stake at 36.24%. Additionally, Hem Finlease Private Limited is the largest public shareholder, owning 2.7%. The company also has some foreign institutional investors (FIIs) holding a combined 0.41%. Individual investors collectively own 20.81% of the shares. There are no pledged promoter holdings, and no mutual funds are currently involved.

How has been the historical performance of the Aprameya Enginee?

Aprameya Enginee's financial performance declined from March 2023 to March 2024, with net sales dropping from Rs 78.12 crore to Rs 65.16 crore and profit after tax decreasing from Rs 5.37 crore to Rs 3.46 crore, despite an increase in total assets. The company faced challenges in revenue generation and profitability, reflected in negative cash flow from operating activities.

Answer:<BR>The historical performance of Aprameya Enginee shows a decline in key financial metrics from March 2023 to March 2024.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2024, Aprameya Enginee reported net sales of Rs 65.16 crore, down from Rs 78.12 crore in the previous year. Total operating income mirrored this decline, remaining at Rs 65.16 crore. The company's total expenditure decreased to Rs 58.80 crore from Rs 68.67 crore, leading to an operating profit (PBDIT) of Rs 6.82 crore, down from Rs 9.66 crore. Profit before tax also fell to Rs 4.60 crore from Rs 7.48 crore, resulting in a profit after tax of Rs 3.46 crore compared to Rs 5.37 crore in the prior year. The earnings per share decreased from Rs 3.84 to Rs 2.47, reflecting a decline in profitability. On the balance sheet, total assets increased to Rs 75.23 crore from Rs 61.73 crore, driven by a rise in current assets, particularly sundry debtors, which grew to Rs 58.06 crore from Rs 41.80 crore. Total liabilities also rose to Rs 75.23 crore, up from Rs 61.73 crore, with total debt increasing significantly to Rs 42.05 crore from Rs 28.74 crore. Cash flow from operating activities remained negative at Rs -9.00 crore, though cash flow from financing activities improved to Rs 11.00 crore from Rs 13.00 crore. Overall, the financial performance indicates challenges in revenue generation and profitability despite growth in total assets.

When is the next results date for Aprameya Enginee?

No Upcoming Board Meetings

Has Aprameya Enginee declared dividend?

No Dividend History Available